Presbyopia-Correcting IOLs
vs LASIK

What premium presbyopia-correcting IOLs do that LASIK can’t

Standard LASIK reshapes the cornea to correct distance vision. It doesn’t restore the eye’s natural ability to shift focus from far to near (accommodation), because accommodation is a function of the crystalline lens, which LASIK doesn’t touch. Mini-monovision LASIK works around this by using the two eyes for two different distances — but each individual eye still has only one focal point.

Premium presbyopia-correcting IOLs approach the problem differently. During refractive lens exchange (RLE) or cataract surgery, the natural lens is removed and replaced with an artificial lens designed to provide multiple focal distances simultaneously. The result: functional vision across near, intermediate, and distance ranges without the monovision offset, in both eyes.

The trade-off is that premium IOLs introduce optical side effects (halos, glare, reduced contrast) that standard LASIK doesn’t. Whether these are worth the near-vision benefit is a highly individual decision.

The main premium IOL platforms in 2026

Multifocal (trifocal) IOLs

Split incoming light between three focal distances: distance, intermediate (roughly 26 inches), and near (roughly 16 inches). Provide the most complete near-vision restoration of any current IOL platform. Trade-offs: pronounced halos and glare at night, meaningful reduction in contrast sensitivity in low light, and 3-12 month neuroadaptation period.

• Alcon PanOptix: The most widely implanted trifocal IOL in the US and international markets. Diffractive design with three focal points. Well-studied outcomes; predictable performance.
• Zeiss AT LISA tri: Widely available in Europe and international markets. Trifocal diffractive design with slightly different focal distances than PanOptix.
• Rayner RayOne Trifocal: UK-designed trifocal. Growing adoption in international markets.

Extended depth-of-focus (EDOF) IOLs

Provide continuous range of clear vision from distance through intermediate, with reduced but often adequate near vision. Fewer halos and glare than trifocal IOLs; less complete near vision (typically require occasional readers for the smallest print). Neuroadaptation typically faster (1-3 months).

• Johnson & Johnson Tecnis Symfony: The most widely implanted EDOF platform. Elongated focus rather than distinct focal points. Excellent outcomes for patients prioritizing distance and intermediate over near.
• Alcon Vivity: Extended vision IOL using wavefront-shaping (non-diffractive) technology. Behaves more like a monofocal with extended range; minimal halos and glare. Less near-vision restoration than trifocals or Symfony.
• Zeiss AT LARA: EDOF diffractive design. Available in international markets.

Accommodating IOLs

Designed to move within the capsular bag with ciliary muscle contraction, shifting focus like the natural lens. In practice, effective accommodation is limited — typically 1-2 diopters at most, and often decreases over time as the capsule fibroses. Less commonly recommended in current practice. Some newer designs are in development.

Monofocal IOLs with monovision offset

Not strictly “premium” presbyopia-correcting, but worth mentioning: two monofocal IOLs targeted for monovision (one eye distance, one eye near) can provide functional binocular vision at all distances without the optical side effects of multifocal or EDOF platforms. Costs less than premium IOLs. The trade-off is the depth-perception impact of monovision.

Cost comparison across five destinations

Here’s 2026 RLE with premium presbyopia-correcting IOL per-eye pricing at ISRS-affiliated hospital-adjacent clinics across five destinations plus the US baseline. Figures reflect the surgical fee plus a mid-tier premium IOL (trifocal or EDOF).

For bilateral premium IOL RLE at Colombia or Turkey pricing, budget $7,000-$8,400 total procedure cost. US pricing for the same case runs $11,000-$15,000. After travel expenses, most patients save $3,500-$6,000 on the trip.

Choosing between LASIK and premium IOLs

Choose LASIK (typically with mini-monovision) if

• You’re 40-52 with a clear natural lens on slit-lamp exam.
• Your refractive prescription is well within LASIK range (roughly -8.00 to +4.00 D).
• You have adequate corneal thickness and healthy corneal topography.
• Your near-vision needs are modest — occasional menus, phone, computer.
• You can accept mini-monovision or occasional reading glasses.
• You prefer the simpler, faster-recovery procedure.
• You want to preserve future flexibility to make lens-based decisions at cataract time.
• Cost is a meaningful factor and the LASIK-vs-RLE price gap changes the decision.

Choose premium IOL RLE if

• You’re 55+ or have any lens changes on pre-op exam.
• You have high hyperopia (farsightedness above +3.00 to +4.00 D) that LASIK handles poorly.
• You have strong near-vision goals for tasks below 16-20 inches.
• You want binocular vision at all distances without monovision offset.
• You’re comfortable with the trade-offs (optical side effects, longer recovery, higher cost).
• You value eliminating future cataract surgery risk.
• You have inadequate corneal thickness or topography that rules out LASIK.

Neither LASIK nor premium IOLs may be ideal if

• You have significant baseline dry-eye that isn’t well-managed.
• You have significant ocular surface disease.
• You have unrealistic expectations of “perfect vision at every distance with no side effects.”
• You cannot commit to the follow-up schedule for either procedure.

Neuroadaptation to premium IOLs

Premium IOLs (particularly multifocal trifocals) require neural adaptation over months. The brain must learn to select and interpret the multiple focal images the IOL produces. This process is highly individual: some patients adapt within days, others take a year, and a small minority never fully adapt.

Typical adaptation timeline:

• Week 1-2: Vision is functional but may feel “strange.” Halos and glare at night are most noticeable during this period.
• Month 1-3: Adaptation typically improving. Near vision beginning to feel natural.
• Month 3-6: Most patients report near-full adaptation. Halos and glare typically reduced but not eliminated.
• Month 6-12: Continued gradual improvement possible. Final adaptation status assessed at 12 months.

Patients who cannot adapt after 12 months are candidates for IOL exchange. This is a more complex procedure than the initial implantation and carries elevated risk. The path forward for a patient who cannot adapt to a trifocal is typically exchange for a monofocal (with monovision if desired), or exchange for an EDOF platform.

Destination comparison for premium IOL candidates

Premium IOL destination factors: platform breadth (which specific IOLs are available), cataract-adjacent expertise (RLE surgeons should have strong cataract surgery foundation), English-fluent consult, flight ease from US, and credentialing depth.

Colombia profiles strongly for premium IOL candidates. Hospital-affiliated centers in Bogotá and Medellín carry the major manufacturer lines (Alcon PanOptix and Vivity, Johnson & Johnson Tecnis, Zeiss AT LISA tri and AT LARA). Cataract surgery volume is high, providing the foundational expertise that premium IOL implantation depends on. Short flight from most US cities makes the multi-visit RLE process practical.

Turkey has arguably the deepest premium IOL platform investment globally. Istanbul centers particularly carry a broad range of platforms, including some newer options not yet available in the US. The trade-off is flight length for US patients.

Mexico offers the shortest flight for US patients. Premium IOL platform availability is strongest at Mexico City and Guadalajara hospital-affiliated centers.

Thailand offers strong platform breadth with the same long-flight trade-off as Turkey.

Costa Rica has good English fluency and reasonable proximity for US East Coast patients; premium IOL platform breadth is narrower than the top-tier destinations.

Questions to ask before choosing a platform

1. What are the specific IOL platforms available at this practice?
2. What is your case volume for each platform in the past 12 months?
3. Which platform do you recommend for my specific case, and why?
4. What are the specific optical side effects I should expect with the recommended platform?
5. What is your enhancement rate for this platform (LASIK touch-up to fine-tune the refractive result)?
6. What is your IOL exchange rate, and under what circumstances do you recommend exchange?
7. How do you handle patients who don’t adapt after 12 months?
8. What is your specific pre-op workup for premium IOL candidates (macular OCT, endothelial cell count, ocular surface assessment)?

Any surgeon proposing premium IOL implantation should be able to answer each of these clearly. If the answers are vague or evasive, get a second opinion.

Frequently asked questions